News Archive

Walbrook PR, one of the UK’s leading providers of Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as PR & IR advisor to Feedback plc (“Feedback”), the specialist medical imaging technology company. The team at Walbrook will manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

Feedback plc (AIM: FDBK) is a medical imaging technology business. Its core product, Bleepa, is a revolutionary medical imaging communications app, providing an easy-to-use, high quality tool to enable remote and secure communications between front-line clinicians and teams. Importantly, it is the only CE marked medical imaging communications platform on the NHSx clinical communications tools framework.

Its highly scalable Software as a Service (“SaaS”)-based revenue model will provide increasing levels of visibility as the Company grows its customer base. With a growing distribution base and technology in place the focus is on leveraging key relationships in order to drive sales both in the UK and internationally to all forms of care facilitators. As a fully certified medical device Bleepa aims to disrupt the medical imaging market and, importantly, increase the accuracy and speed of diagnosis.

Paul McManus, Founder and Managing Director of Walbrook PR, commented: “We are looking forward to working with the team at Feedback, a very exciting business that is transforming the use of medical imaging software in frontline clinical care. The Bleepa product has huge potential as the only communications platform compliant with the Medical Device Directive and considered a Class 1 Medical Device. It is an ideal tool for sharing clinical grade medical images with colleagues whilst following local lockdown restrictions or maintaining social distancing.”

“Feedback is a hidden gem on the AIM market with huge potential and we look forward to building their profile amongst financial journalists, analysts and investors.”

For more information, visit the Company’s website: https://fbkmed.com/feedback-plc/

 

For further information please contact:

Paul McManus

Tel: 020 7933 8787

Mob: 07980 541 893

paul.mcmanus@walbrookpr.com

About Walbrook PR:                                                                                              www.walbrookpr.com

Walbrook PR was founded in April 2009 by Paul McManus and focuses on providing high quality Financial PR and Investor Relations to Small Cap and AIM listed companies.

Walbrook PR is ranked joint 1st by number of listed Healthcare clients in the Corporate Advisers Rankings Guide (August 2020) and ranked 3rd by number of AIM listed companies. Walbrook is ranked 7th by total number of Stock Market listed clients and acts for 47 listed companies across a wide mix of sectors.

Walbrook PR prides itself on having a strong reputation for working with growing UK Small Cap and AIM listed companies; a proven IR offering, which focuses on the Private Client Investment Management community and the retail investment community; and on having a proactive, hands-on approach from a committed team with full ownership of the business.